Detalles de la búsqueda
1.
Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective.
Rev Endocr Metab Disord
; 25(1): 109-121, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37380825
2.
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Cancer
; 128(24): 4203-4212, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36259380
3.
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(8): 1126-1138, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237250
4.
AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma.
Pediatr Blood Cancer
; 66(7): e27707, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30924609
5.
Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
Cytogenet Genome Res
; 150(3-4): 194-207, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28231576
6.
Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients.
Endocrine
; 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296913
7.
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study.
Thyroid
; 34(3): 347-359, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38062732
8.
Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Eur Thyroid J
; 13(2)2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38290210
9.
External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long-term local disease control?
Head Neck
; 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38445804
10.
Neutrophil-to-lymphocyte ratio as an independent factor for worse prognosis in radioiodine refractory thyroid cancer patients.
Endocrine
; 81(1): 141-148, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905576
11.
Guidelines from the Brazilian society of surgical oncology regarding indications and technical aspects of neck dissection in papillary, follicular, and medullary thyroid cancers.
Arch Endocrinol Metab
; 67(4): e000607, 2023 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37252696
12.
An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
Thyroid
; 33(1): 82-90, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36222615
13.
Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy.
Clin Endocrinol (Oxf)
; 77(1): 132-8, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22248037
14.
Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).
Arch Endocrinol Metab
; 66(4): 522-532, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36074944
15.
Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?
Eur Thyroid J
; 11(2)2022 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113037
16.
Neutrophil to lymphocyte ratio as a prognosis biomarker of PRRT in NET patients.
Endocrine
; 78(1): 177-185, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35829985
17.
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).
J Clin Oncol
; 40(17): 1870-1878, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192411
18.
Clinical decision support analysis of a microRNA-based thyroid molecular classifier: A real-world, prospective and multicentre validation study.
EBioMedicine
; 82: 104137, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35785619
19.
Pregnancy has no significant impact on the prognosis of differentiated thyroid cancer.
Arch Endocrinol Metab
; 65(6): 768-777, 2021 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34762783
20.
Prognostic factors in patients with advanced differentiated thyroid cancer treated with multikinase inhibitors - a single Brazilian center experience.
Arch Endocrinol Metab
; 65(4): 411-420, 2021 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939907